PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 33 results · Social Media & Digital · Immunology & Rheumatology  · Clear
🔒 Subscribers only
AUTH/2912/12/16
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Astellas Pharma Europe
Astellas Pharma Europe voluntarily admitted that three videos containing Betmiga (mirabegron) product claims had been posted online by third parties, potentially promoting a prescription-only medic…
Clauses: NONE
🔒 Subscribers only
AUTH/2871/8/16
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Janssen
Janssen-Cilag voluntarily admitted that a Crohn’s disease “awareness” campaign initiated/approved by the Janssen European team was used in the UK and amounted to pre-licence promotion.The cam…
Clauses: 3.2,9.1
🔒 Subscribers only
AUTH/2868/8/16
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Sanofi Genzyme
Janssen complained that at the EULAR Congress of Rheumatology (London, June 2016) Sanofi Genzyme promoted its forthcoming IL-6 receptor blocker, sarilumab, before it had a marketing authorization.T…
Clauses: 9.1
🔒 Subscribers only
AUTH/2592/4/13
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
GSK
GlaxoSmithKline (GSK) voluntarily admitted that two promotional patient case studies for Benlysta (belimumab) were emailed to health professionals as electronic “Dear Doctor” letters before cer…
Clauses: 9.1,9.2
🔒 Subscribers only
AUTH/2575/2/13
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Gedeon Richter
An ex-employee complained about “save the date” invitations for an Esmya (ulipristal acetate) meeting in Barcelona (April 2013), which were accessible via an events company website.The invitati…
Clauses: NONE
🔒 Subscribers only
AUTH/2674/11/13
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous, contactable member of the public complained about a published transparency study: “Clinical Trial Transparency: an assessment of the disclosure results of company-sponsored trials a…
Clauses: NONE
🔒 Subscribers only
AUTH/2577/2/13
Social Media & Digital Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
AbbVie
AbbVie voluntarily admitted that out-of-date prescribing information (PI) was linked to an online Humira (adalimumab) banner ad (ref AXHUR111644a) and included in a hard copy journal ad (ref AXHUR1…
Clauses: 4.1
🔒 Subscribers only
AUTH/2160/8/08
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Wyeth v Roche and Chugai
Wyeth complained about Roche Products Ltd and Chugai Pharma Europe Ltd media activities regarding unlicensed Actemra (tocilizumab), being co-developed for rheumatoid arthritis.Inter-company dialogu…
Clauses: NONE
🔒 Subscribers only
AUTH/1937/1/07
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Wyeth
The head of medicines management at a primary care trust complained about an online advertisement for Enbrel (etanercept) seen on www.yahoo.com on 13 December 2006.The complainant alleged the ad co…
Clauses: NONE
← Prev 1 2 Page 2 of 2 — 33 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews